MANAGEMENT OF HYPERTENSIVE PDA

Objective: To determine different treatment options in patients of Patent Ductus Arteriosus with pulmonary hypertension beyond neonatal period. Study Design: Descriptive cross sectional study. Place and Duration of Study: This study was carried out in Pediatric Cardiology department of Rawalpi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Khushal Khan Khattak, Maad Ullah, Abdul Malik Sheikh, Asma Kanwal, Sajid Ali Shah, Noor -Un- Nisa
Formato:	article
Lenguaje:	EN
Publicado:	Army Medical College Rawalpindi 2020
Materias:	eisenmenger syndrome patent ductus arteriosus pulmonary artery hypertension pda device surgical pda ligation Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/68c50d2a7b6c4f06ad87c24215992299
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:68c50d2a7b6c4f06ad87c24215992299
record_format	dspace
spelling	oai:doaj.org-article:68c50d2a7b6c4f06ad87c242159922992021-12-02T17:11:32ZMANAGEMENT OF HYPERTENSIVE PDAdoi.org/10.51253/pafmj.v70iSuppl-4.60030030-96482411-8842https://doaj.org/article/68c50d2a7b6c4f06ad87c242159922992020-12-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/6003https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To determine different treatment options in patients of Patent Ductus Arteriosus with pulmonary hypertension beyond neonatal period. Study Design: Descriptive cross sectional study. Place and Duration of Study: This study was carried out in Pediatric Cardiology department of Rawalpindi Institute of Cardiology, from Jan 2017 to Jan 2019. Methodology: Patients having PDA with pulmonary hypertension were included in the study. Treatment options were divided into percutaneous catheter device closure, surgical ligation of patent ductus arteriosus and palliative treatment. Any adverse event during the procedure was documented. Stratification was done in regard to gender and age group. Post stratification chi square test was applied and p-value less than or equal to 0.05 was considered as significant. Results: Total number of patients included in the study were 37. Mean age (years) of patients (Mean ± SD) was 19.21 ± 8.76. Mean ± SD pulmonary artery pressure was 56.43 ± 11.55 mmHg. Percutaneous catheter device closure was successful in 24 (64.9%) patients, in 7 (18.9%) patients primary surgical PDA ligation was done, 3 (8.1%) patients were advised palliative treatment and in 3 (8.1%) patients adverse events occurred during percutaneous device closure and were thus referred for surgical ligation. Patent ductus Arteriosus Occlutech device was used in 18 (48.6%) patients, Occlutech VSD device was used in 7 (18.5%) patients and in 1 (2.7%) patient AGA duct occluder was used. Conclusion: In patients with patent ductus arteriosus and pulmonary artery hypertension, percutaneous catheter device closure is a safe and effective procedure.Khushal Khan KhattakMaad UllahAbdul Malik SheikhAsma KanwalSajid Ali ShahNoor -Un- NisaArmy Medical College Rawalpindiarticleeisenmenger syndromepatent ductus arteriosuspulmonary artery hypertensionpda devicesurgical pda ligationMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 70, Iss 4, Pp 701-705 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	eisenmenger syndrome patent ductus arteriosus pulmonary artery hypertension pda device surgical pda ligation Medicine R Medicine (General) R5-920
spellingShingle	eisenmenger syndrome patent ductus arteriosus pulmonary artery hypertension pda device surgical pda ligation Medicine R Medicine (General) R5-920 Khushal Khan Khattak Maad Ullah Abdul Malik Sheikh Asma Kanwal Sajid Ali Shah Noor -Un- Nisa MANAGEMENT OF HYPERTENSIVE PDA
description	Objective: To determine different treatment options in patients of Patent Ductus Arteriosus with pulmonary hypertension beyond neonatal period. Study Design: Descriptive cross sectional study. Place and Duration of Study: This study was carried out in Pediatric Cardiology department of Rawalpindi Institute of Cardiology, from Jan 2017 to Jan 2019. Methodology: Patients having PDA with pulmonary hypertension were included in the study. Treatment options were divided into percutaneous catheter device closure, surgical ligation of patent ductus arteriosus and palliative treatment. Any adverse event during the procedure was documented. Stratification was done in regard to gender and age group. Post stratification chi square test was applied and p-value less than or equal to 0.05 was considered as significant. Results: Total number of patients included in the study were 37. Mean age (years) of patients (Mean ± SD) was 19.21 ± 8.76. Mean ± SD pulmonary artery pressure was 56.43 ± 11.55 mmHg. Percutaneous catheter device closure was successful in 24 (64.9%) patients, in 7 (18.9%) patients primary surgical PDA ligation was done, 3 (8.1%) patients were advised palliative treatment and in 3 (8.1%) patients adverse events occurred during percutaneous device closure and were thus referred for surgical ligation. Patent ductus Arteriosus Occlutech device was used in 18 (48.6%) patients, Occlutech VSD device was used in 7 (18.5%) patients and in 1 (2.7%) patient AGA duct occluder was used. Conclusion: In patients with patent ductus arteriosus and pulmonary artery hypertension, percutaneous catheter device closure is a safe and effective procedure.
format	article
author	Khushal Khan Khattak Maad Ullah Abdul Malik Sheikh Asma Kanwal Sajid Ali Shah Noor -Un- Nisa
author_facet	Khushal Khan Khattak Maad Ullah Abdul Malik Sheikh Asma Kanwal Sajid Ali Shah Noor -Un- Nisa
author_sort	Khushal Khan Khattak
title	MANAGEMENT OF HYPERTENSIVE PDA
title_short	MANAGEMENT OF HYPERTENSIVE PDA
title_full	MANAGEMENT OF HYPERTENSIVE PDA
title_fullStr	MANAGEMENT OF HYPERTENSIVE PDA
title_full_unstemmed	MANAGEMENT OF HYPERTENSIVE PDA
title_sort	management of hypertensive pda
publisher	Army Medical College Rawalpindi
publishDate	2020
url	https://doaj.org/article/68c50d2a7b6c4f06ad87c24215992299
work_keys_str_mv	AT khushalkhankhattak managementofhypertensivepda AT maadullah managementofhypertensivepda AT abdulmaliksheikh managementofhypertensivepda AT asmakanwal managementofhypertensivepda AT sajidalishah managementofhypertensivepda AT noorunnisa managementofhypertensivepda
_version_	1718381501944430592

MANAGEMENT OF HYPERTENSIVE PDA

Ejemplares similares